COVID-19: Moderna ‘Spikevax’ vaccine gets full US approval
The US Food and Drug Administration announced Monday that it had granted full approval to Moderna’s COVID-19 “Spikevax” vaccine, which had previously received an emergency use authorisation in the United States. “The public can be assured that Spikevax meets the FDA’s high standards for safety, effectiveness and manufacturing quality required of any vaccine approved for…